Bone Marrow Transplantation, 0268-3369

Journal

1 - 10 out of 45Page size: 10

Publications

  1. 2018
  2. E-pub ahead of print

    Current status and future clinical directions in the prevention and treatment of relapse following hematopoietic transplantation for acute myeloid and lymphoblastic leukemia

    Charles Craddock, 31 May 2018, In: Bone Marrow Transplantation. 11 p.

    Research output: Contribution to journal › Review article › peer-review

  3. 2017
  4. Published

    Allogeneic transplantation in primary refractory AML

    Paul Ferguson & Charles Craddock, Jul 2017, In: Bone Marrow Transplantation. 52, p. 950-951

    Research output: Contribution to journal › Article › peer-review

  5. Published

    Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

    Charles Craddock & 2 others, , Feb 2017, In: Bone Marrow Transplantation. 52, 2, p. 209-215 7 p.

    Research output: Contribution to journal › Article › peer-review

  6. Published

    Obituary: Professor David Grimwade (1962-2016)

    Sylvie Freeman & Charles Craddock, Feb 2017, In: Bone Marrow Transplantation. 52, 2, p. 171-172 2 p.

    Research output: Contribution to journal › Article

  7. 2016
  8. Published

    Greatly reduced risk of EBV reactivation in Rituximab-experienced recipients of Alemtuzumab-conditioned allogeneic HSCT

    David Burns, Emma Martin, Andrew Bell, Paul Moss, Charles Craddock, Christopher Fox & Sridhar Chaganti, Jun 2016, In: Bone Marrow Transplantation. 51, 6, p. 825-832

    Research output: Contribution to journal › Article › peer-review

  9. Published

    Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties

    Charles Craddock, 1 Mar 2016, In: Bone Marrow Transplantation. 51, 3, p. 418-423 6 p.

    Research output: Contribution to journal › Article › peer-review

  10. 2015
  11. E-pub ahead of print

    Exacerbation of IgA nephropathy following G-CSF administration for PBSC collection: suggestions for better donor screening

    Charles Craddock, 5 Oct 2015, In: Bone Marrow Transplantation. 51, 2, p. 286-287 2 p.

    Research output: Contribution to journal › Letter › peer-review

  12. Published

    Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT.

    Charles Craddock, 2015, In: Bone Marrow Transplantation.

    Research output: Contribution to journal › Article › peer-review

  13. Published

    In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?

    Charles Craddock, 2015, In: Bone Marrow Transplantation.

    Research output: Contribution to journal › Article › peer-review

  14. 2014
  15. Published

    Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma

    May 2014, In: Bone Marrow Transplantation. 49, p. 671-678 8 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 3 4 5 Next